Restricted genetic heterogeneity of the Plasmodium vivax transmission-blocking vaccine (TBV) candidate Pvs48/45 in a low transmission setting: Implications for the Plasmodium vivax malaria vaccine development-Reference-Cited by-同舟云学术

Restricted genetic heterogeneity of the Plasmodium vivax transmission-blocking vaccine (TBV) candidate Pvs48/45 in a low transmission setting: Implications for the Plasmodium vivax malaria vaccine development

Published:2021-04 Issue: Volume:89 Page:104710
ISSN:1567-1348
Container-title:Infection, Genetics and Evolution
language:en
Short-container-title:Infection, Genetics and Evolution

Author:

Asali Soheila,Raz Abbasali,Turki Habibollah,Mafakher Ladan,Razmjou Elham,Solaymani-Mohammadi Shahram

Funder

University of North Dakota

National Institute of General Medical Sciences

Iran University of Medical Sciences

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),Genetics,Molecular Biology,Ecology, Evolution, Behavior and Systematics,Microbiology

Reference102 articles.

1. Polymorphisms in genes associated with drug resistance of Plasmodium vivax in India;Anantabotla;Parasitol. Int.,2019

2. The immunology of Plasmodium vivax malaria;Antonelli;Immunol. Rev.,2020

3. Plasmodium vivax: transmission-blocking immunity in a malaria-endemic area of Colombia;Arevalo-Herrera;Am. J. Trop. Med. Hyg.,2005

4. Recombinant Pvs48/45 antigen expressed in E. coli generates antibodies that block malaria transmission in Anopheles albimanus mosquitoes;Arevalo-Herrera;PLoS One,2015

5. Molecular epidemiology of malaria in endemic areas of Iran;Assmar;Southeast Asian J. Trop. Med. Public Health,2003

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards Eradication of Malaria: Is the WHO’s RTS,S/AS01 Vaccination Effective Enough?;Risk Management and Healthcare Policy;2021-03